Metropolis Healthcare Ltd
Metropolis Healthcare Ltd (METROPOLIS) last reported results for the quarter ended Jun 2026, with sales of ₹450 crore and net profit of ₹57 crore. The stock last traded at ₹540, a market capitalisation of ₹11,195 crore, on a P/E of 53.8. Over the past 52 weeks the stock has ranged between ₹412 and ₹609. Figures are as of 6 Oct 2026 and are not real time.
Metropolis Healthcare Ltd share price and key metrics
- Current price
- ₹540
- Market cap
- ₹11,195 cr
- Stock P/E
- 53.8
- Book value
- ₹73
- ROE
- 13.6%
- ROCE
- 17.8%
- Dividend yield
- 0.36%
- 52w high / low
- 609/412
Metrics as of 6 Oct 2026. Not real time.
Track Metropolis Healthcare Ltd
Cruxal reads every Metropolis Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Metropolis Healthcare Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 11%
- 3 Years
- 13%
- TTM
- 22%
- 10 Years
- 11%
- 5 Years
- 1%
- 3 Years
- 11%
- TTM
- 37%
- 10 Years
- %
- 5 Years
- -4%
- 3 Years
- 15%
- 1 Year
- 7%
- 10 Years
- 19%
- 5 Years
- 15%
- 3 Years
- 12%
- Last Year
- 14%
Metropolis Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹450 cr, up 16.6% from ₹386 cr a year earlier. Net profit was ₹57 cr, up 26.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 350 | 323 | 345 | 386 | 429 | 406 | 425 | 450 |
| Expenses | 260 | 251 | 283 | 296 | 321 | 311 | 317 | 339 |
| Operating profit | 90 | 72 | 62 | 90 | 108 | 95 | 108 | 111 |
| OPM % | 26% | 22% | 18% | 23% | 25% | 23% | 25% | 25% |
| Other income | 3 | 3 | 7 | 8 | 1 | -0 | 8 | 5 |
| Interest | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 6 |
| Depreciation | 27 | 28 | 29 | 31 | 32 | 32 | 39 | 32 |
| Profit before tax | 61 | 42 | 36 | 61 | 71 | 57 | 70 | 78 |
| Tax % | 24% | 26% | 19% | 26% | 26% | 26% | 27% | 27% |
| Net profit | 47 | 31 | 29 | 45 | 53 | 42 | 51 | 57 |
| EPS (₹) | 2.27 | 1.53 | 1.41 | 2.17 | 2.54 | 2.00 | 2.46 | 2.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Metropolis Healthcare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 545 | 647 | 761 | 856 | 998 | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 | 1,710 |
| Operating profit | 140 | 181 | 203 | 237 | 290 | 348 | 293 | 288 | 308 | 406 | 422 |
| OPM % | 26% | 28% | 27% | 28% | 29% | 28% | 26% | 24% | 23% | 25% | 25% |
| Net profit | 107 | 112 | 124 | 128 | 183 | 215 | 143 | 128 | 146 | 191 | 203 |
| EPS (₹) | 26.61 | 27.29 | 5.99 | 6.29 | 8.95 | 10.46 | 6.98 | 6.24 | 7.00 | 9.17 | 9.73 |
TTM is the trailing twelve months to the most recent quarter.
Metropolis Healthcare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 41 |
| Reserves | 314 | 405 | 408 | 513 | 696 | 876 | 978 | 1,086 | 1,321 | 1,472 |
| Borrowings | 1 | 1 | 18 | 67 | 112 | 379 | 266 | 197 | 204 | 232 |
| Other liabilities | 188 | 110 | 113 | 160 | 181 | 256 | 240 | 254 | 324 | 386 |
| Total liabilities | 512 | 526 | 550 | 750 | 1,000 | 1,521 | 1,495 | 1,547 | 1,859 | 2,131 |
| Fixed assets | 202 | 207 | 213 | 296 | 343 | 1,059 | 1,121 | 1,177 | 1,447 | 1,601 |
| CWIP | 1 | 0 | 6 | 3 | 0 | 6 | 20 | 0 | 0 | 0 |
| Investments | 142 | 102 | 33 | 14 | 10 | 16 | 15 | 55 | 71 | 142 |
| Other assets | 167 | 216 | 298 | 437 | 647 | 440 | 340 | 316 | 341 | 387 |
| Total assets | 512 | 526 | 550 | 750 | 1,000 | 1,521 | 1,495 | 1,547 | 1,859 | 2,131 |
As reported by the company. Total assets equal total liabilities by construction.
Metropolis Healthcare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 102 | 104 | 90 | 215 | 249 | 253 | 247 | 264 | 263 | 351 |
| Cash from investing | -86 | 1 | 36 | -104 | 63 | -736 | 48 | -89 | -199 | -220 |
| Cash from financing | -17 | -87 | -118 | -55 | -33 | 163 | -292 | -181 | -87 | -115 |
| Net cash flow | -1 | 18 | 8 | 56 | 279 | -321 | 3 | -6 | -23 | 15 |
| Free cash flow | 45 | 90 | 67 | 179 | 221 | 223 | 195 | 200 | 196 | 300 |
| CFO / operating profit | 109% | 89% | 78% | 118% | 106% | 96% | 102% | 105% | 99% | 98% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Metropolis Healthcare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 46% | 43% | 43% | 40% | 36% | 29% | 17% | 16% | 15% | 18% |
| Debtor days | 54 | 57 | 66 | 55 | 45 | 40 | 39 | 38 | 41 | 38 |
| Inventory days | 38 | 53 | 55 | 44 | 59 | 68 | 64 | 58 | 65 | 51 |
| Days payable | 97 | 88 | 90 | 152 | 160 | 136 | 136 | 150 | 171 | 146 |
| Cash conversion cycle | -5 | 21 | 30 | -54 | -56 | -29 | -33 | -53 | -65 | -57 |
| Working capital days | -27 | 28 | 33 | 2 | -9 | -26 | -22 | -16 | -18 | -15 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Metropolis Healthcare Ltd shareholding pattern
Promoters held 48.86% at Jun 2026, broadly unchanged since Jun 2025. FIIs 11.03% and DIIs 35.12%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.43% | 49.40% | 48.89% | 48.89% | 48.89% | 48.87% | 48.86% | 48.86% |
| FIIs | 18.56% | 16.73% | 15.29% | 12.83% | 12.52% | 11.68% | 10.43% | 11.03% |
| DIIs | 28.02% | 30.00% | 30.30% | 32.40% | 33.10% | 34.73% | 35.80% | 35.12% |
| Public | 3.98% | 3.86% | 5.51% | 5.87% | 5.48% | 4.69% | 4.92% | 5.00% |
| No. of shareholders | 51,852 | 48,572 | 49,293 | 50,015 | 47,846 | 46,670 | 49,175 | 50,636 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Metropolis Healthcare Ltd
Metropolis Healthcare Ltd corporate filings
- Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026Company Updatelow impact
- Metropolis Healthcare Q2FY27 Business Update: No Significant Financial Changes ReportedCompany Updatelow impact
Cruxal's analysis: The company issued a routine business update for Q2FY27 on October 5, 2026, with no…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Metropolis Healthcare allots 66,312 equity shares under ESOP 2020Company Updatelow impact
Cruxal's analysis: Metropolis Healthcare has allotted 66,312 equity shares to eligible employees under the…
Read the full analysis - Metropolis Healthcare Ltd files disclosure under Regulation 30 regarding corporate restructuringCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has submitted a disclosure under Regulation 30 of the SEBI (Listing…
Read the full analysis - Franklin Templeton Mutual Fund Increases Stake in Metropolis Healthcare to 5.10%Insider Trading / SASTmedium impact
Cruxal's analysis: Metropolis Healthcare Ltd has received a disclosure indicating that Franklin Templeton…
Read the full analysis - Metropolis Healthcare Outlines Strategic Growth Roadmap Targeting 14%-15% Revenue CAGR and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited, in its recent investor and analyst meet, reaffirmed its…
Read the full analysis - Metropolis Healthcare releases audio recording of Investor and Analyst meetCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has filed the audio recording of its recent Investor and Analyst…
Read the full analysis - Metropolis Healthcare Ltd files routine regulatory disclosure under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Metropolis Healthcare has submitted a routine disclosure under Regulation 30 of the SEBI…
Read the full analysis - Metropolis Healthcare outlines three-year growth strategy targeting 14-15% revenue CAGR and EBITDA margin expansion to 27-28%Company Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited has released an investor presentation detailing a…
Read the full analysis - Metropolis Healthcare Ltd files routine disclosure under Regulation 30 regarding corporate restructuringCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has submitted a disclosure under Regulation 30 of the SEBI (Listing…
Read the full analysis - Metropolis Healthcare schedules analyst and institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has announced a scheduled meeting with analysts and institutional…
Read the full analysis - Metropolis Healthcare Limited Announces Voting Results of 26th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Metropolis Healthcare Limited has released the Scrutinizer's Report for its 26th Annual…
Read the full analysis - Metropolis Healthcare Limited concludes 26th Annual General Meeting; confirms interim dividends and auditor appointmentAGM/EGMlow impact
Cruxal's analysis: Metropolis Healthcare Limited has successfully concluded its 26th Annual General Meeting…
Read the full analysis - Metz Advisory LLP, a promoter entity of Metropolis Healthcare Limited, sells 10.5 lakh equity shares via open marketInsider Trading / SASTmedium impact
Cruxal's analysis: Metz Advisory LLP, part of the promoter group of Metropolis Healthcare Limited, has…
Read the full analysis - Metropolis Healthcare Promoter Group Divests 0.51% Stake via Open Market SaleInsider Trading / SASTmedium impact
Cruxal's analysis: Metropolis Healthcare Limited has disclosed that the Duru Shah Family Trust, a member of…
Read the full analysis - Metropolis Healthcare Q1 FY27 Earnings: Revenue Grows 17% YoY to INR 450 Crore with EBITDA Margin Expansion to 25.2%Company Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited reported a strong Q1 FY27 performance with revenue of INR…
Read the full analysis - Metropolis Healthcare Limited files audio recording of Q1 FY27 earnings conference callCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare Limited has formally filed the audio recording of its earnings…
Read the full analysis - Metropolis Healthcare Ltd publishes routine newspaper advertisement regarding financial resultsCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare Ltd has fulfilled its regulatory obligation under Regulation 30 of…
Read the full analysis - Metropolis Healthcare Q1 FY27 Results: Revenue Grows 17% YoY to INR 450 Crore with Strong Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited reported a strong Q1 FY27 performance with revenue from…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.